SCIENTIFIC ADVISORY

2019-     Janssen Pharmaceuticals (Consultation): Development of gene therapy for inherited retinal disease

2019-     NightStar (Consultation): Development of gene therapy for inherited retinal disease

2018-     Sanofi Genzyme (Consultation): Development of gene therapy for inherited retinal disease

2018-     Novartis AG (Consultation): Development of gene therapy for inherited retinal disease

2018-     Acucela Inc., (Consultation): Development of gene therapy and compound therapy for inherited retinal disease

2017-    Kubota Pharmaceutical Holdings Co., Ltd, (Consultation): Development of gene therapy and compound therapy for inherited retinal disease

Division for Vision Research, National Institute of Sensory Organs

© 2016 by Kaoru Fujinami. Proudly created with Wix.com

  • Facebook Clean Grey
  • Twitter Clean Grey
  • LinkedIn Clean Grey

UCL Institute of Ophthalmology associated with Moorfields Eye Hospital